Localized Therapeutics

Here is the rewritten version using your scientific writing style:

We have developed a biotechnology company that focuses on therapeutic resonance technologies. The company aims to treat cancer through resonance-based targeting of abnormal cells while preserving healthy tissue.

The technology operates through identification of resonance frequencies specific to cancer cells. The treatment protocol involves obtaining a tumor biopsy from the patient, determining the unique resonance frequencies of the tumor DNA, and generating those specific frequencies to destroy the cancer cells.

The team consists of scientists and healthcare professionals working to develop this treatment approach. The company conducts testing and clinical trials to establish safety and efficacy of the technology.

The market for this technology is substantial. Cancer remains a major cause of mortality globally, and current treatments often produce significant side effects and result in chronic health complications for patients. The therapeutic resonance technology provides targeted treatment that may reduce these limitations.

The company has developed a stationary device for cancer treatment using therapeutic resonance. The device measures approximately the size of a notebook computer, allowing for use in home or hospital settings. The treatment requires no special preparation or maintenance procedures.

The company operates at pre-revenue stage and has received federal and private research grants. The company seeks $2 million in funding to produce the therapeutic resonance device within one year, followed by clinical trials to test safety and efficacy. Based on clinical trial outcomes, the company will either release the product directly to market or license the technology to established medical device companies.

The therapeutic resonance technology represents a novel approach to cancer treatment. The company aims to provide safer and more targeted treatment options to patients and healthcare providers. Through development of the therapeutic resonance device, testing protocols, and clinical trials, the company works toward bringing this technology to clinical use.

The company requests $2 million in venture capital funding to support device development and market entry. The investment will support technology development with potential applications in cancer treatment. The therapeutic resonance approach may provide new treatment options for cancer and other diseases.